BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 15, 2026
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Celia trial: data strong, analysts skeptical
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Phase IIb trial of SB-509 does not meet primary or secondary endpoints
Oct. 4, 2011
Studies assess 2-year and sustained-release ONO-5334 therapy
Oct. 4, 2011
GlaxoSmithKline reports new SAP-binding proteins
Oct. 3, 2011
FDA reviews safety of drospirenone-containing birth control pills
Oct. 3, 2011
Biodel announces phase I data on experimental insulins
Sep. 30, 2011
Aegerion gives update on European filing for lomitapide
Sep. 30, 2011
Synageva BioPharma expands ongoing study in LAL deficiency
Sep. 30, 2011
Takeda files for approval of TAK-085 in Japan
Sep. 29, 2011
New PPAR-gamma agonists synthesized in Japan
Sep. 29, 2011
Denosumab shows long-term safety and efficacy in postmenopausal osteoporosis
Sep. 29, 2011
Previous
1
2
…
605
606
607
608
609
610
611
612
613
…
1800
1801
Next
RSS